SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
ArQule, Inc. (ARQL)
An SI Board Since April 2003
Posts SubjectMarks Bans Symbol
545 40 0 ARQL
Emcee:  tuck Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
70Maybe, but the PI might be more visible than we thought, and I would expect it ttuck-11/17/2003
69Nice move on calling the top..see $4 again?mopgcw-11/16/2003
68OT: for those who can't keep their minds out of the gutter: >>You'tuck-11/7/2003
67Doc, I'm sure I speak for all here on the board in thanking you for your hetuck-11/7/2003
66Hi Tuck, They're substituting beta-lapachone. Preferred compounds of formuDr. Voodoo-11/6/2003
65Article on tweaking beta lapachone: arkat-usa.org Contains various chemical sttuck-11/6/2003
64The PNAS article is available in full now: Selective killing of cancer cells bytuck-11/6/2003
63[B-Lap as modulator of male fertility] >>J Med Food. 2003 Fall;6(3):201-8tuck-11/4/2003
62>> King Neptune << You've put the red dress aside for a bit?scaram(o)uche-10/28/2003
61Thanks for doing this digging! (eom)scaram(o)uche-10/28/2003
60Link to presentation: corporate-ir.netmopgcw-10/28/2003
59THANKS! I appreciate the sharing. (eom).mopgcw-10/28/2003
58WRT to the Jiang patent on solubility issues, the other side of that is systemictuck-10/28/2003
57Possible competitor: slil.com This patent application describes the synthesis tuck-10/28/2003
56This application addresses solubility issues of beta lapachone by the usual methtuck-10/28/2003
55Patent search commencing, here's the first I found: patft.uspto.gov Which tuck-10/28/2003
54[NQO1 as intracellular target of beta lapachone] Which suggests breast, colon, tuck-10/28/2003
53>>Curr Cancer Drug Targets. 2002 Sep;2(3):227-42. Cancer therapy with btuck-10/28/2003
52<i>good basic chemistry company with contract services that will bring in nigel bates-10/28/2003
51Yes, Garren added ArQule to his model portfolio last Thursday, saying: <<JMarcus-10/28/2003
50Looks pretty standard to me. You want solid pre-clinical tox, and the program wscaram(o)uche-10/24/2003
49Rick, Or someone with more expertise in trial design than I, can you help clarituck-10/24/2003
48Wow, up-to-date stuff now, too? THANKS! (eom)scaram(o)uche-10/24/2003
47I stared at it yesterday when it was in the .50's..........tom pope-10/24/2003
46sheeeet. too slow am i. up 14% now.mopgcw-10/24/2003
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News